1. SWOT Analysis
    2. ›
  2. Healthcare
    3. ›
  3. AstraZeneca SWOT Analysis

AstraZeneca SWOT Analysis

Here is a detailed SWOT analysis of AstraZeneca covering strengths, weaknesses, opportunities and threats.

Published by MBA Skool Team in Pharma and Healthcare category Read time:

AstraZeneca Strengths

  1. Rapid decision making & streamlined due diligence processing
  2. Good commercial and R&D presence in emerging markets
  3. Active in over 100 countries employing over 60,000 people
  4. High investment in R&D with 11,000+ dedicated R&D team
  5. Ten products with global sales above 1 billion dollar
  6. Product portfolio includes cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation medicines

Above are the strengths in the SWOT Analysis of AstraZeneca. The strengths of AstraZeneca looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.

  • Weakness

    1. It was affected by drug shortage crisis as in case of Cefotan
    2. Product discontinuation affects the performance
    3. Legal proceedings related to patents and pricing issues affect image

    These were the weaknesses in the AstraZeneca SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.

    AstraZeneca Opportunities

    1. It can leverage its strong presence in emerging markets
    2. Increasing importance of biosimiler market
    3. Increasing global ageing population

    Above we covered the opportunities in AstraZeneca SWOT Analysis. The opportunities for any brand can include prospects of future growth.

    AstraZeneca Threats

    1. Seroqueltheir blockbuster drug is facing threat of copycat generic drugs
    2. Stringent drug development guidelines
    3. Competition coming up with effective drugs

    The threats in the SWOT Analysis of AstraZeneca are as mentioned above. The threats for any business can be external factors which can negatively impact its business.

    Hence this concludes the AstraZeneca SWOT analysis.

    About AstraZeneca

    The table below gives the brand overview along with its target market, segmentation, positioning & USP

    AstraZeneca Overview
    Parent Company

    AstraZeneca Biopharmaceuticals
    Category

    Pharmaceutical
    Sector

    Pharma and Healthcare
    Tagline/ Slogan

    Health connects us all
    USP

    AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.
    AstraZeneca STP
    Segmentation

    Cardiovascular, neuroscience, gastrointestinal, oncology, infection & respiratory diseases
    Target Market

    Healthcare professionals, doctors, hospitals offering treatments for above mentioned diseases
    Positioning

    They are responsible for development of prescription medicines for six important areas of healthcare such as cancer, infection.


    This article has been researched & authored by the Content & Research Team which comprises of MBA students, management professionals, and industry experts. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

    Browse marketing analysis of more brands and companies similar to AstraZeneca. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.

    Continue Reading:


    The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
    Edit the brand or add a new one to SWOT Analysis section : Contribute

    Share this Page on:
    Facebook ShareTweetShare on Linkedin